Loading company details...
Beta
Latest Form 4 (Oct 13, 2026): Michael H. Tardugno (Executive Chairman of Board): Grant/Award of 7,800 shares, $8.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Michael H. Tardugno, Executive Chairman of Board | Grant/Award | 7,800 | $8.4K |
| Oct 13, 2026 | Stacy Lindborg, President and CEO | Grant/Award | 2,977 | $3.2K |
| Oct 13, 2026 | Douglas Vincent Faller, Chief Medical Officer | Grant/Award | 1,249 | $1.3K |
| Sep 28, 2026 | Michael H. Tardugno, Executive Chairman of Board | Grant/Award | 7,169 | $10.1K |
| Sep 28, 2026 | Stacy Lindborg, President and CEO | Grant/Award | 6,697 | $9.4K |
| Sep 28, 2026 | Douglas Vincent Faller, Chief Medical Officer | Grant/Award | 4,390 | $6.2K |
| Sep 15, 2026 | Michael H. Tardugno, Executive Chairman of Board | Grant/Award | 5,824 | $8.6K |
| Sep 15, 2026 | Stacy Lindborg, President and CEO | Grant/Award | 5,504 | $8.1K |
| Sep 15, 2026 | Douglas Vincent Faller, Chief Medical Officer | Grant/Award | 4,211 | $6.2K |
| Sep 1, 2026 | Michael H. Tardugno, Executive Chairman of Board | Grant/Award | 7,371 | $11.8K |